Literature DB >> 24237839

The assessment of lens opacity postmortem and its implication in forensics.

Valter Stemberga1, Anja Petaros, Damir Kovacevic, Miran Coklo, Neven Simicevic, Alan Bosnar.   

Abstract

Visual impairment, mostly due to cataracts, has been demonstrated to be an important factor associated with traffic accidents. Although vision screening is standard procedure during licensing in order to prevent motor vehicle accidents, an eye exam is not typically administered after an accident has already occurred. Postmortem assessment of lens opacity in victims of car accidents would provide helpful information for attesting to the liability of the parties in specific accidents, determining the circumstances of the accident, and developing preventive measures for both drivers and pedestrians alike. In this paper, we explore the use of different methods and their limitations for assessing lens opacity postmortem. We discuss the possible use and benefits of a simple, but as-yet untested method: retrobulbar translucency. The method would be based on the recording of shadows formed by opaque regions of the lens while the eye is illuminated from the back with a rigid source of light. The efficacy and objectivity of the method, its reproducibility, and the inter- and intra-observer error should be tested before implementing such a technique to be regularly used to determine lens opacity in cadavers.
Copyright © 2013 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.

Entities:  

Keywords:  Car accident; Legal medicine; Lens; Lens opacity; Postmortem

Mesh:

Year:  2013        PMID: 24237839     DOI: 10.1016/j.jflm.2013.08.007

Source DB:  PubMed          Journal:  J Forensic Leg Med        ISSN: 1752-928X            Impact factor:   1.614


  1 in total

1.  Postmortem Ocular Findings in the Optical Coherence Tomography Era: A Proof of Concept Study Based on Six Forensic Cases.

Authors:  Matteo Nioi; Pietro Emanuele Napoli; Roberto Demontis; Emanuela Locci; Maurizio Fossarello; Ernesto d'Aloja
Journal:  Diagnostics (Basel)       Date:  2021-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.